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Abstract 23 
Background  24 
Instability and low bioavailability of polyphenols greatly limit their potential health benefits 25 
in preventing aging, cancer, inflammation and neurodegenerative diseases. Utilization of 26 
protected encapsulation and delivery system can improve the stability and bioavailability of 27 
polyphenols. A wide range of technologies have been developed to encapsulate polyphenols. 28 
Among these, emulsion-encapsulation is regarded as one of the most promising techniques 29 
for protection and delivery of polyphenols, due to its high-efficiency encapsulation, 30 
maintenance of chemical stability and controlled release. 31 
Scope and Approach  32 
In this review, preparation, applications and limitations of emulsion-based encapsulation and 33 
delivery systems for polyphenols, including single, multiple and nano-emulsions, are 34 
discussed. 35 
Key Findings and Conclusions 36 
Utilization of encapsulated polyphenols instead of free molecules improves both the stability 37 
and bioavailability of the molecules in vitro and in vivo. Many emulsion-based delivery 38 
systems for polyphenols have been well established, including single, multiple and nano-39 
emulsions. However, variations in composition and preparation technologies result in the 40 
formation of a range of emulsions of new properties with great potential in delivery of 41 
polyphenols or other bioactive nutrients, e.g., using unsaturated fatty acids as the oil phase, 42 
which can achieve the delivery of multiple nutrients at the same time. Furthermore, very few 43 
studies have been done on the in vivo absorption, transportation and release of polyphenols 44 
incorporated emulsions, which are essential to their deeper and wider applications. Hence, 45 
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systematic and intensive investigation of metabolism and physiological effects of 46 
encapsulated polyphenols or other potential bioactive nutrients in vivo are required. 47 
 48 
Keywords: polyphenol, encapsulation, delivery, emulsion 49 
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Introduction 65 
    Polyphenols are a structural class of mainly natural, but also synthetic or semisynthetic, 66 
organic chemicals, which are characterized by the presence of large multiples of phenol 67 
structural units; they widely exist in numerous natural plants and foods, e.g., herbs, fruits and 68 
vegetables (Fig. 1). Although plant-derived products have been used in Asia for centuries, the 69 
term polyphenol has only been in use since 1894 (Prasad, 2014). Their biological effects and 70 
their values in human health have been demonstrated during the last two decades. 71 
    Polyphenols are widely regarded as a major groups of highly effective antioxidants, since 72 
they exhibit potent free radical scavenging capability and protections against oxidation of 73 
transition metals and lipid peroxidation (Zhou & Elias, 2013). However, biological effects of 74 
these phytochemicals have turned out to be more complex than originally expected. They can 75 
inhibit cancer cell proliferation and cholesterol uptake (Leifert & Abeywardena, 2008; 76 
Noratto, Porter, Byrne, & Cisneros-Zevallos, 2009), regulate transcription, expression and 77 
mode of action of different enzymes including telomerase (Naasani, et al., 2003), 78 
cyclooxygenase (Hussain, Gupta, Adhami, & Mukhtar, 2005; O’Leary, et al., 2004) and 79 
lipoxygenase (Rocio de la Puerta, Gutierrez, & Hoult, 1999; Sadik, Sies, & Schewe, 2003; 80 
Schewe, et al., 2001), participate in several signal transduction pathways (Kong, Yu, Chen, 81 
Mandlekar, & Primiano, 2000; Masella, et al., 2004; Rosenblat & Aviram, 2009; Spencer, 82 
Rice-Evans, & Williams, 2003; Wiseman, Mulder, & Rietveld, 2001), and modulate cell 83 
cycle and platelet functions (Murphy, et al., 2003). Polyphenols can also prevent endothelial 84 
dysfunctions (Carluccio, et al., 2003). 85 
    However, low bioavailability and instability of polyphenols in digestion and absorption 86 
process greatly limits their health benefits. In fact, only a small proportion of them taken 87 
orally are absorbed, because of insufficient gastric residence time, low permeability, and 88 
water-solubility (Wildman, 2006). In addition, they are sensitive to physical and chemical 89 
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conditions, such as light, heat and oxidation (Munin & Edwards-Levy, 2011). The delivery of 90 
these compounds therefore requires protection mechanisms that can maintain their chemical 91 
integrity and deliver them to the physiological target (Chen, Remondetto, & Subirade, 2006).  92 
    A wide range of technologies have been developed to encapsulate polyphenols, including 93 
spray drying, coacervation, emulsions, liposomes, micelle, nanoparticles, freeze-drying, 94 
cocrystallization and yeast encapsulation (Fang & Bhandari, 2010; Munin & Edwards-Levy, 95 
2011). Each of these has its own specific strengths and weaknesses in encapsulation, 96 
protection, delivery, cost, regulatory status, ease of use, biodegradability and biocompatibility. 97 
Among these, emulsions are widely considered as one of the most popular encapsulation and 98 
delivery systems for a wide range of lipophilic, hydrophilic and amphiphilic bioactive 99 
molecules (McClements & Li, 2010), due to their high-efficiency encapsulation, maintenance 100 
of chemical stability of encapsulated molecules (Klinkesorn, 2005) and controlled 101 
release(Mao, Roos, & Miao, 2013). Furthermore, some emulsion-encapsulated polyphenols 102 
presented even higher biological activities compared with pure free molecules (Wang et al, 103 
2008). 104 
    An emulsion consist of two immiscible liquids, usually oil and water, with one of the 105 
liquid being dispersed as the small spherical droplets in the other. Emulsions can be classified 106 
according to the relative spatial distribution of the oil and aqueous phase (McClements, 2005). 107 
A system that consists of oil droplets dispersed in an aqueous phase is called an oil-in-water 108 
(O/W) emulsion, e.g., milk and soups; while a system that consists of water droplets 109 
dispersed in an oil phase is called a water-in-oil (W/O) emulsion, e.g., butter. In the last two 110 
decades, a variety of emulsions with desirable structures and properties have been 111 
successfully developed for the protected encapsulation and delivery of many kinds of 112 
bioactive nutrients with significant health benefits (McClements, 2010, 2012; Norton, 113 
Espinosa, Watson, Spyropoulos, & Norton, 2015). Emulsions are thus essential encapsulation 114 
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systems in many particular applications, especially in the food industry. Formulation, 115 
structure-functionality relationship and delivery behaviours of emulsions are also the focus of 116 
current research.  117 
This review summarizes the literature focusing on the preparation, applications and 118 
limitations of emulsion-based systems for encapsulation and delivery of polyphenols, their 119 
applications in the nutrition, health and pharmaceuticals areas, and the development of 120 
emulsions as the delivery systems. Oil-in-water single emulsions, water-in-oil-in water 121 
double emulsions and nanoemulsions are mainly discussed. 122 
 123 
Properties of Polyphenols and their limitations in applications 124 
    The molecular structure, physicochemical properties, and health benefits of various 125 
polyphenols have been reported by many previous studies, and properties of some 126 
representative polyphenols are shown in Table 1. 127 
In general, all these compounds have a poor solubility in water but can be easily dissolved 128 
in organic solvents, except EGCG, which is soluble in both. Their appearances are normally 129 
coloured crystals or powders, with melting points ranging from 183℃ (curcumin) to above 130 
360℃ (ellagic acid).   131 
These polyphenols possess a variety of health benefits, e.g., antioxidant activity and 132 
prevention of cancer, diabetes, inflammation, virus, thrombus, cardiovascular and Alzheimer’s 133 
diseases, as well as UV radiation protection and hepatoprotective activities.  Among these, 134 
antioxidant activity is one of the most clearly documented health benefits of polyphenols.  135 
Indeed, polyphenols’ protective effects against human diseases are mainly attributed to their 136 
significant antioxidant activity, e.g., scavenging of reactive oxygen species (ROS), since high 137 
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levels of ROS are widely reported to be correlated with a number of human disease 138 
conditions, such as those listed in Table 1.  139 
In spite of the notable therapeutic potentials of polyphenols which have been confirmed by 140 
both in vitro and in vivo studies, some limitations can also be clearly observed, as shown in 141 
Table 1. To sum up, there are four main problems in their applications: (i) poor water 142 
solubility inducing a low bioavailability, e.g., curcumin, resveratrol, quercetin and ellagic 143 
acid; (ii) instability under exposure to light and/or certain pH conditions, e.g., resveratrol, 144 
quercetin or ellagic acid; (iii) poor oral and gastrointestinal absorption (due to degradation, 145 
low permeability or rapid metabolism), e.g., EGCG, curcumin, resveratrol, quercetin or 146 
ellagic acid; and (iv) very short half-life and rapid elimination from the body, e.g., EGCG, 147 
resveratrol, or ellagic acid. All of these factors potentially will lead to a loss in bioavailability 148 
of these compounds and thus reduced potential health benefits.  149 
Novel emulsion-based protection and delivery strategies to overcome these problems will 150 
be discussed in the following sections. 151 
 152 
Oil-in-water single emulsions for protected encapsulation of polyphenols 153 
    Conventional oil-in-water (O/W) emulsions consist of oil droplets dispersed in an aqueous 154 
continuous phase, with the oil droplets being surrounded by a thin interfacial layer consisting 155 
of emulsifier molecules (Fig. 2). The concentration and particle size distribution of the oil 156 
droplets in emulsions can be controlled by oil phase proportion and preparation technologies. 157 
The oil droplets typically have diameters between 0.1 and 100 µm while the interfacial layer 158 
is generally between 1 nm and 10 nm thick for emulsifiers (McClements, Decker, & Weiss, 159 
2007), e.g., surfactants, phospholipids, proteins, or polysaccharides (McClements, 2005). The 160 
electrical charge on the droplets can be controlled by selecting an appropriately charged 161 
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emulsifier, which may be positive, un-charged, or negative (Dickinson, 1992; Friberg, 162 
Larsson, & Sjoblom, 2003).  163 
A variety of methods can be used to prepare polyphenols encapsulated in O/W emulsions, 164 
including homogenization, homogenization-solvent removal, emulsion-cooling and 165 
interfacial polycondensation. 166 
    Homogenization is the process of converting two immiscible liquids into an emulsion, and 167 
the classical device designed to carry out this process is called a homogenizer (Walstra, 1993). 168 
The preparation of an emulsion system directly from two separate liquids will be considered 169 
as primary homogenization, whereas the reduction of droplet size in existing emulsions is 170 
defined as secondary homogenization; the preparation of emulsions always involves the use 171 
of one or both of these homogenization processes (Binks, 1998). Properties of emulsions 172 
prepared by homogenization are often largely affected by the homogenization conditions 173 
used, including temperature, pressure and cycles (Yuan, Gao, Zhao, & Mao, 2008). These 174 
properties mainly include droplet size, stability and viscosity. Hence, emulsions with desired 175 
properties can be achieved by controlling the homogenization conditions for targeted 176 
encapsulation and delivery of polyphenols. 177 
    A canola oil O/W emulsion stabilized by ι-carrageenan and β-lactoglobulin with a droplet 178 
size of about 400 nm, which incorporated  epigallocatechin-3-gallate (EGCG), was 179 
successfully prepared by high-pressure homogenization (Ru, Yu, & Huang, 2010). The 180 
emulsion-encapsulated EGCG showed enhanced in vitro anticancer activity compared to the 181 
free EGCG (Fig. 3). Another O/W system with even smaller droplet size (<200 nm) was 182 
successfully prepared for the encapsulation of resveratrol (Donsì, Sessa, Mediouni, Mgaidi, 183 
& Ferrari, 2011). This emulsion system remained stable for 4 weeks and protected resveratrol 184 
from oxidation while maintaining its antioxidant activity. 185 
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In addition to the functional evaluation of encapsulated polyphenols, researchers have also 186 
investigated the in vitro digestion behaviour of oil droplets in O/W emulsions prepared by 187 
high-pressure homogenization (Ahmed, Li, McClements, & Xiao, 2012). O/W emulsions 188 
were prepared with different lipids of long-, medium- and short-chain triacylglycerols (LCT, 189 
MCT and SCT, respectively) for encapsulation of curcumin. Under the simulated intestinal 190 
digestive environment, the length of the triacylglycerol chain can significantly influenced the 191 
initial digestion rate (SCT > MCT > LCT), final digestion extension of the lipid phase (MCT > 192 
SCT > LCT) and the bioaccessibility of encapsulated curcumin (MCT > LCT > SCT).  193 
    Homogenization-solvent removal methods have been well established for encapsulation of 194 
a variety of polyphenols and improve both their stability and bioavailability. These processes 195 
are based on evaporation or extraction (Fig. 4) of the internal phase of an emulsion, resulting 196 
in the precipitation of the coating polymer in the form of particles while trapping the active 197 
ingredients (Munin & Edwards-Levy, 2011). In the solvent evaporation method, the polymer 198 
used to trap the bioactive nutrients is first dissolved in a volatile organic solvent which has a 199 
very low miscibility with water. The active compound is dispersed in the polymer solution; 200 
then, water containing emulsifier is added and the mixture is homogenized to obtain an O/W 201 
emulsion. Evaporation of the volatile organic solvent is performed upon heating and/or under 202 
vacuum to form the bioactive ingredients encapsulated in nanoparticles. In the solvent 203 
extraction method, the solvent used to dissolve the polymer must be completely miscible with 204 
water and this polymer solution is injected under agitation into a continuous water phase 205 
containing a water-soluble emulsifier. The polymer, insoluble in the mixture of water and 206 
volatile solvent, precipitates to form nanoparticles, while entrapping the active ingredient. 207 
    The homogenization-solvent removal method has been well developed for encapsulation of 208 
polyphenol compounds in last a few years, including quercetin (Kumari, et al., 2011; Kumari, 209 
Yadav, Pakade, Singh, & Yadav, 2010; Wu, et al., 2008), ellagic acid (Bala, et al., 2006; 210 
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Sonaje, et al., 2007), EGCG (Italia, Datta, Ankola, & Kumar, 2008; Onoue, Ochi, & Yamada, 211 
2011; Siddiqui, et al., 2009), resveratrol (Shao, et al., 2009) and curcumin (Tsai, et al., 2011). 212 
Encapsulated polyphenols obtained by this method are always solid nanoparticle powders. 213 
Biopolymers, e.g., PLA and PLGA, are mainly used as matrixes to form nanoparticles that 214 
entrap the polyphenols (Table 2). Encapsulation of polyphenols based on this method can 215 
achieve high encapsulation efficiency, and encapsulated polyphenol compounds showed a 216 
large increase in their solubility and physical or chemical stability. Furthermore, compared 217 
with free compounds, functional evaluations in these studies confirmed strengthened 218 
biological effects, such as antioxidant and anti-cancer activity, of encapsulated polyphenol 219 
compounds in vitro and in vivo. Moreover, a significant improvement in in vivo intestinal 220 
absorption efficiency of polyphenols was also observed by using emulsion encapsulation 221 
technology based on emulsification-solvent removal methods (Table 2).  222 
This  method has also been successfully used to encapsulate polyphenol mixtures, 223 
including catechin (Taylor, Taylor, Belton, & innaar, 2009), tea polyphenol (Yaolan, 224 
Caihuan, Yingzhou, Shaoyu, & Shihai, 2000) and bayberry polyphenol (Zheng, Ding, Zhang, 225 
& Sun, 2011). The utilization of encapsulated polyphenol mixtures can significantly improve 226 
their storage stability while maintaining their antioxidant activity. In addition, these 227 
encapsulated polyphenol mixtures also showed a sustained or controlled release pattern, 228 
which is largely influenced by the environments (pH or enzymes).  229 
    Emulsion-cooling process consists of dissolving or dispersing the active compound in a 230 
lipid phase, which is then emulsified in a continuous aqueous phase (Vandamme, Poncelet, 231 
Subra-Paternault, & Benameur, 2007). The formation process of an emulsion is always 232 
maintained at a higher temperature than the melting point of the lipid phase and rapid cooling 233 
of the emulsion will generate lipid nanoparticles, in which bioactive ingredients are 234 
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encapsulated. The process allows the encapsulation of hydrophilic or lipophilic molecules if a 235 
continuous phase is chosen within which these molecules do not have sufficient solubility. 236 
    The emulsion-cooling method has been employed to prepare curcumin-encapsulated lipid 237 
nanoparticles; encapsulated curcumin was very stable when kept at 4 ℃ or 30℃ for 20 days 238 
(Donsì, et al., 2011). Preparation of EGCG-encapsulated lipid-nanocapsules (LNC) using this 239 
method has been reported, with a high encapsulation rate of 95% and stability of over 4 240 
weeks in water, whereas free molecules in water showed 100% degradation within 4 h 241 
(Barras, et al., 2009). The method can also be used to encapsulate quercetin. Incorporation of 242 
quercetin into lipid-nanocapsules (LNC) dramatically increased its aqueous solubility (100-243 
fold), improved physical instability (creaming or flocculation) and protected it from oxidation 244 
and light-induced decomposition (Barras, et al., 2009; Scalia & Mezzena, 2009). The most 245 
promising emulsion system was shown to be stable for at least 10 weeks. Furthermore, 246 
encapsulated quercetin showed a much higher transdermal absorption efficiency and 247 
enhanced antioxidant and anti-inflammation activity (Chen-yu, et al., 2012). All these results 248 
suggest that incorporation of quercetin into lipid-nanoparticles represents an effective 249 
strategy for enhancing its solubility, stability and bioavailability. 250 
    Interfacial polycondensation is a rapid, irreversible polymerization at the interface between 251 
aqueous solvent containing one reactant and an immiscible organic solvent containing a 252 
complementary reactant. It is based on the Schotten-Baumann reaction, in which acid 253 
chlorides are reacted with compounds containing active hydrogen atoms (-OH, -NH and -SH) 254 
(Wittbecker & Morgan, 1959). A large number of polymers (heat-sensitive and infusible as 255 
well as stable and meltable) can be prepared by this method. Interfacial polycondensation can 256 
also be used for the preparation of emulsion-based encapsulation systems, also known as 257 
emulsion diffusion methods (Janssen & Te Nijenhuis, 1992). This method for entrapment of 258 
bioactive ingredients is an attractive process for prohibiting light-induced oxidation with high 259 
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encapsulation efficiency (Choi, Soottitantawat, Nuchuchua, Min, & Ruktanonchai, 2009). 260 
Bouchemal et al (Bouchemal, et al., 2004) used an interfacial polycondensation combined 261 
with emulsification to encapsulate vitamin E, which is sensitive to light, heat and oxygen. 262 
The nanoencapsulation achieved by this method has many advantages, e.g., high 263 
encapsulation efficiency, better particle size control, and enhanced stability (Montasser, 264 
Briançon, & Fessi, 2007). 265 
Interfacial polycondensation reactions have also been employed to encapsulate polyphenol 266 
compounds. Solid microparticles incorporating proanthocyanidin (GPO), a polyphenol 267 
extracted from grape seed, have been created using this method (Andry, Vezin, Dumistracel, 268 
Bernier, & Lévy, 1998). GPO-encapsulated polymers, formed by interfacial 269 
polycondensation, constituted the coating membrane of microparticles. GPO protected in this 270 
way showed an improved physical stability while maintaining its radical-scavenging activity. 271 
An optimized emulsion diffusion method was used to prepare polyurea and polyurethane 272 
nanoparticles for the encapsulation of curcumin, and more detailed investigation on the 273 
microstructure of nanoparticles has been done (Souguir, Salaün, Douillet, Vroman, & 274 
Chatterjee, 2013). Fourier transform infrared spectroscopy (FTIR) analysis confirmed the 275 
encapsulation of curcumin and differential scanning calorimetry (DSC) detection showed that 276 
the encapsulated molecule was found in an amorphous phase. Furthermore, the percentage of 277 
surfactant, organic solvent content, and hydrophilic monomer are the main factors that 278 
influenced the encapsulation efficiency, while the choice of monomer affected the particle 279 
size distribution mode as well as the mean diameter. 280 
    O/W emulsions show many potential advantages as encapsulation and delivery systems for 281 
lipophilic polyphenols. Firstly, physical and chemical stability of encapsulated polyphenols 282 
can be well protected by designing the oil-water interface or controlling the physical location 283 
of polyphenols (Mao, et al., 2013; Mao, Roos, & Miao, 2012). In addition, it is possible to 284 
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design emulsions with different rheological properties, which can meet some specific 285 
applications in delivery of lipophilic polyphenols (Genovese, Lozano, & Rao, 2007). 286 
Furthermore, O/W emulsions can either be used in wet state (Chen-yu, et al., 2012; Ru, et al., 287 
2010) or be dried to solid powders (Kumari, et al., 2011; Kumari, et al., 2010), which greatly 288 
facilitates their processing, transportation, storage and thus the application in encapsulation 289 
and delivery of polyphenols.  290 
In spite of O/W emulsions have been widely employed as delivery system for a variety of 291 
bioactive nutrients and show huge potentials as delivery system, there are still some 292 
disadvantages. For example, O/W emulsions are usually sensitive to environmental stress, 293 
such as heating, chilling, extreme pH and salt concentrations, all of which can lead to their 294 
physical and chemical instability, e.g., creaming, flocculation, coalescence, breaking and 295 
Ostwald ripening for common physical instability (Fig. 5) (Becher, 1996; Dickinson, 2010), 296 
and oxidation and hydrolysis for their common chemical instability (McClements & Decker, 297 
2000). All these instabilities can potentially cause damage or even break-down of emulsions, 298 
and accordingly will decrease physical and chemical stability of encapsulated polyphenols 299 
and thus their final beneficial effects. In addition, it is challenging to precisely control the 300 
release of encapsulated polyphenols in O/W emulsions, because the simple oil-water interface 301 
structure in O/W emulsion result in a very short time for diffusion of encapsulated 302 
polyphenols from inside to the outside of the oil droplets (McClements, et al., 2007). 303 
Therefore, emulsions with more sophisticated structures are required for some particular 304 
applications. 305 
 306 
Water-in-oil-in-water double emulsions for the encapsulation of polyphenols 307 
    Water-in-oil-in-water (W/O/W) double emulsions consist of small water droplets contained 308 
within larger oil droplets that are dispersed in an aqueous continuous phase (McClements, 309 
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2005) (Fig. 6). W/O/W emulsions can also be more clearly defined as W1/O/W2 emulsions, 310 
where W1 is the inner water phase while W2 is the outer water phase. In principle, it is 311 
possible to design properties of inner water phase and oil phase, e.g., droplets size and 312 
distribution, surface charge, and interfaces between water and oil, such as surface charge, and 313 
environmental response behaviours.  314 
    Polymer capsules formed by the  solvent evaporation of a W/O/W emulsion have been 315 
developed, and shown to control the release of encapsulated riboflavin-5′-phosphate (R5-P) 316 
(Koo, et al., 2008), a light-sensitive polyphenol molecule, which acts as a prosthetic group for 317 
various oxidoreductases, as well as a cofactor in biological blue-light photo receptors. The 318 
heterogeneous wall formed efficiently blocked the sun-light and hence stabilizes photo-319 
sensitive R5-P. This encapsulation technology potentially can be utilized to stabilize a wide 320 
variety of photo-sensitive, water-soluble molecules, which may lead to practical applications 321 
in many fields. Other technologies, such as mechanical agitation and membrane 322 
emulsification, have been developed to prepare stable W/O/W double emulsion with 323 
polyphenol-encapsulation capability. High initial encapsulation efficiency (EE) of resveratrol 324 
in a W/O/W emulsion is achieved by employing proper inner or external phase emulsifier or 325 
their combination with an external continuous water phase solution, which may result in a 326 
synergetic effect and thus a higher initial EE (Matos, Gutiérrez, Coca, & Pazos, 2014).  327 
W/O/W double emulsion systems can also be employed to co-encapsulate both hydrophilic 328 
catechin and hydrophobic curcumin simultaneously by using a two-step emulsification 329 
method (Aditya, et al., 2015). This fabricated system showed a synergistic effect between the 330 
components; encapsulation of curcumin and catechin increased their stability and 331 
bioavailability, and the presence of catechin and curcumin helped to reduce the droplet size 332 
of the emulsion.  333 
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    Compared with O/W emulsions, W/O/W emulsions are ideal protected encapsulation 334 
systems for hydrophilic polyphenols. These compounds can be trapped in the internal water 335 
phase, which is isolated from the outer water phase by the oil phase, preventing their 336 
diffusion across the water-oil interface into the outer water phase (Benichou, Aserin, & Garti, 337 
2004; McClements, 2015). Furthermore, release of polyphenols entrapped within the inner 338 
water phase will be prolonged and can be controlled (Garti & Bisperink, 1998). Moreover, 339 
W/O/W emulsions can be also designed to encapsulate both lipophilic and hydrophilic 340 
bioactive polyphenols at the same time (Cournarie, et al., 2004), which will achieve multiple 341 
targeted delivery of multiple bioactive compounds in one particular system. Another potential 342 
advantage of W/O/W emulsions is that they can be structured to have the same dispersed 343 
phase volume and droplets size as conventional O/W emulsions, but with lower fat content, 344 
which facilitate the development of functional food products with encapsulated polyphenols , 345 
which have lower-fat content but the same properties as the full-fat products (McClements, et 346 
al., 2007). 347 
However, W/O/W emulsions, like conventional O/W emulsions, are also highly 348 
susceptible to environmental stresses (thermal processing, freeze and dehydration), which can 349 
induce instability, such as conventional flocculation, coalescence, and Ostwald ripening (Fig. 350 
5), which potentially will influence the delivery of encapsulated polyphenols. Furthermore, 351 
the diffusion of encapsulated hydrophilic polyphenols or water molecules from the inner to 352 
the outer aqueous phase or expulsion of whole water droplets from oil droplets, induced by 353 
limited solubility of encapsulated compounds in oil phase, can also lead to the instability of 354 
W/O/W emulsions (Garti, 1997; McClements, 2015). Moreover, polyphenols encapsulated in 355 
the inner water phase of W/O/W emulsions can gradually diffuse into the oil phase or even 356 
outer water phase, due to their amphiphilic properties, which potentially will change their 357 
release pattern and thus influence expected controlled-release and targeted-delivery.  358 
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Many strategies have been developed to overcome these problems, including use pf 359 
combinations of oil- and water-soluble emulsifiers, incorporation of biopolymers into the 360 
outer water phase, and osmotic balancing of the inner and outer water phases to prevent water 361 
diffusion (Garti & Benichou, 2004). 362 
 363 
Nanoemulsions: advanced delivery system for polyphenols 364 
    Nanoemulsions are metastable dispersions of sub-100-nm droplets of one liquid in a 365 
different immiscible liquid(Mason, Wilking, Meleson, Chang, & Graves, 2006). A 366 
nanoemulsion can be considered to be a conventional emulsion that contains very small 367 
droplets. A wide range of technologies can be used to prepare both O/W or W/O 368 
nanoemulsions. High-flow homogenization provides a simple route to forming nanoscale 369 
droplets, wherein externally applied shear and/ or elongational flow overcome the interfacial 370 
and internal viscous stress to rupture bigger droplets into smaller droplets; examples of this 371 
include high-pressure microfluidic homogenization (Meleson, Graves, & Mason, 2004) or 372 
ultrasonic emulsification (Leong, Wooster, Kentish, & Ashokkumar, 2009).  373 
Compared with conventional emulsions, nanoemulsions represent a more stable physical 374 
system to gravitational separation and aggregation than conventional emulsions, due to their 375 
smaller droplets size and higher liquid droplet interface area (Fryd & Mason, 2012). 376 
Nanoemulsions can be nearly transparent, because their relatively small droplet size (r<λ/4) 377 
results in less scattering of visible spectrum (Mason, et al., 2006); nanoemulsion exhibits very 378 
different rheological properties, e.g., viscosity, elasticity, and response to shear (Russel, 379 
Saville, & Schowalter, 1992), which make it possible to modify or design the texture of food 380 
products (McClements, 2011). Nanoemulsion is reported to show a wide applications in food 381 
and nutrition, biology and pharmacology areas, especially in the high-efficiency 382 
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encapsulation and targeted delivery of bioactive ingredients (Ezhilarasi, Karthik, Chhanwal, 383 
& Anandharamakrishnan, 2012).  384 
Nanoemulsion-encapsulation of EGCG significantly improved its in vitro neuronal α-385 
secretase enhancing activity and in vivo bioavailability (Smith, et al., 2010), which was 386 
doubled compared with free EGCG. The study demonstrated the ability of nanoparticles to 387 
increase the systemic absorption of EGCG taken orally; it is likely that the small diameter of 388 
these particles will also lead to improved blood-brain barrier penetration. Nanoemulsion 389 
encapsulation can also be used to promote the bioavailability of curcumin while maintaining 390 
its biological activities (Anand, et al., 2010). Encapsulated curcumin (EC), compared with 391 
free compounds, exhibited very rapid and more efficient in vitro cellular uptake; EC was 392 
more bioavailable and had a longer half-life than free curcumin in vivo (Fig. 7). Furthermore, 393 
EC was also more active in inhibiting TNF-induced NF-κB activation and thus showed 394 
effects in regulating cell proliferation, invasion and angiogenesis.  395 
    A number of studies have shown that the bioavailability of lipophilic components 396 
encapsulated in lipid droplets increased when the droplets size decreased (Acosta, 2009). 397 
There are several possible reasons for this increase. Firstly, Nanoemulsion always shows a 398 
very rapid release of encapsulated compounds ( t1/2<1 ms) (McClements, 2005), due to their 399 
small droplets; a large surface area of small droplets leads to their quick digestion so that 400 
encapsulated molecules are released easily. Secondly, small droplets are more easily to be 401 
absorbed into lymphatic vessels through the mucous layer that coats the epithelium cells 402 
within the small intestine (Jenkinsa, 1994). Thirdly, small particles can be directly 403 
transported across the epithelia mucus via paracellular, endocytosis and mucosa-associated 404 
lymphoid tissues (MALT) mechanisms (Lu, et al., 2012). 405 
Compared with conventional emulsions with droplet size ranging from 100 nm-100 µm, 406 
nanoemulsions showed better stability to gravitational separation, flocculation and 407 
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coalescence (McClements, 2011), but worse stability  to Ostwald ripening (Taylor, 1998), a 408 
process of net migration of dispersed-phase molecules from smaller droplets into larger 409 
droplets. However, nanoemulsions are more susceptible to chemical degradation due to their 410 
large specific surface area of oil-water interface and transparency caused by small droplet 411 
size.   412 
 413 
Summary and future trends 414 
       Studies on encapsulation and delivery of polyphenols by emulsion-based delivery 415 
systems have been reviewed. It is clear that utilization of encapsulated polyphenols instead of 416 
free molecules improves both the stability and bioavailability of the molecules in vitro and in 417 
vivo. Many emulsion-based encapsulation and delivery systems for polyphenols have been 418 
well established, including single, multiple, and nano-emulsions. However, variations in 419 
composition and preparation technologies result in the formation of a range of emulsions with 420 
novel properties, which may show even greater potentials in delivery of polyphenols. Studies 421 
on these emulsions will contribute to the establishments of high-performance delivery 422 
systems and extend the application of both polyphenols and emulsions, e.g., using 423 
unsaturated fatty acids as the oil phase of polyphenol-encapsulated emulsion, which can 424 
achieve the delivery of multiple nutrients (unsaturated fatty acids and polyphenols) at the 425 
same time. Furthermore, very few preliminary studies have evaluated the in vivo absorption, 426 
transportation and targeted release of polyphenol incorporated emulsions, which are essential 427 
to their deeper and wider applications. Hence, systematic and intensive investigation of in 428 
vivo metabolic mechanism and physiological effects of encapsulated polyphenols or any 429 
other bioactive nutrients are urgently required.  430 
Actually, at present, the applications of free polyphenols or encapsulated compounds are 431 
mainly used as functional foods or nutraceutical due to the fact that there are still limited 432 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
- 19 - 
 
evidence justifying the use of polyphenols in prevention and treatment of human diseases. 433 
However, it can be predicted that, with a better understanding of molecular structure and 434 
function mechanisms of polyphenols, emulsion-based delivery systems with high-435 
performance in protected encapsulation, controlled release, and potential site-specific 436 
targeted delivery will play an important role in increasing the efficiency of encapsulated 437 
polyphenols in biology or even pharmaceuticals. There is no doubt that the progress of 438 
encapsulation technology will also contribute to a faster and better development of bioactive 439 
phytochemicals, not only as food additives or nutritional supplements, but also as active 440 
biological products or even as drugs, all of which will potentially benefit human health. 441 
 442 
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Figure captions 694 
 695 
Fig. 1 Classification of polyphenols  696 
 697 
Fig. 2 Preparation of single emulsions with homogenization technology 698 
 699 
Fig. 3 Cellular anticancer assay of free EGCG and submicrometer emulsion encapsulated EGCG on 700 
HepG2 cells.  Human hepatocellular caricinoma (HepG2) cell were cultured in MEM containing 10% 701 
fetal bovine serum and antibiotics and were maintained at 37℃ with 5% CO2. In vitro anticancer 702 
assay was performed using MTT assay. After treatment with free EGCG or EGCG-encapsulated 703 
emulsion with the same concentration for 24 h, cells were treated with MTT and optical absorbance at 704 
560 and 670 nm was recorded. Relative viability of cells was expressed as A560-A670. Data were 705 
presented as mean (standard deviation with four repeats (n = 4) (Ru et al, 2010). 706 
 707 
Fig. 4 Solvent removal technology for preparation of bioactive nutrients encapsulated emulsion.  (a) 708 
All non-water soluble ingredients such as polymers and the bioactive ingredient to be encapsulated 709 
are first dissolved in an organic solvent. (b) This solution is mixed with a water phase, which includes 710 
an emulsifier, and stirred in to form an emulsion. (c) The organic solvent is removed from the droplets 711 
by an extraction process, adding additional amount of water. During this stage, the polymers 712 
immigrate to the interface of the capsule and the water, forming a solid wall around the active 713 
compound. (d) The microcapsules are then washed and filtered and dried using a lyophilization 714 
process. 715 
 716 
Fig. 5. Typical physical instability of emulsion. (a) Stable emulsion. (b) Coalescence. (c)  717 
Flocculation. (d) Creaming. (e) Breaking. 718 
 719 
Fig. 6. Two steps of multiple water-in-oil-in-water (W1/O/W2) emulsion preparation 720 
 721 
Fig. 7. Bioavailability of free curcumin and encapsulated-curcumin (NP).  Mice were divided into two 722 
groups (6 mice in each group), group one was given free curcumin and group two was given 723 
encapsulated-curcumin (NP). Free curcumin and NP were administered intravenously (2.5 mg/kg) and 724 
the blood was collected at different time intervals. Serum was separated and the concentration of 725 
curcumin was  determined by HPLC analysis. (Anand et al, 2010) 726 
 727 
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Table 1 Molecular structure, physicochemical properties, and health benefits of mainly-reported polyphenols and their limitations in applications 
 
 
Polyphenol 
 
Molecular structure 
 
Physicochemical properties 
 
Reported health benefits 
 
Limitations in application 
 
References 
 
 
 
 
EGCG 
 
 
the ester of epigallocatechin 
and gallic acid, a type of 
catechin; soluble in water and 
organic solvents 
 
Antioxidant activity, and UV 
radiation protection, as well as 
preventing thrombus, cancer, 
diabetes, and cardiovascular 
diseases 
 
Low bioavailability due to its 
containing many hydrogen bond 
donors or acceptors; poor 
stability in gastrointestinal tract 
(GI); low intestinal permeability 
and short plasma half life 
 
Nagle, 2006; 
Kumari, 2011; 
Lipinski, 2012; 
Italia, 2008; 
Onoue, 2011; 
Siddiqui, 2009 
Barras, 2009 
 
 
Curcumin 
 
A diarylheptanoid; bright 
yellow-orange powder with 
melting point of 183 ℃; 
insoluble in water and soluble 
in organic solvents and 
alkaline solutions 
Antioxidant and 
antiinflammation, as well as 
preventing cancers, major 
depressed disorder, 
myelodysplastic syndromes,  
and Alzheimer’s disease 
Extremely insoluble in water 
and low bioavailability; poorly 
absorbed in gut and metabolism 
fast in liver; degradation in 
alkaline pH conditions and 
under exposure to light    
Ahmed, 2012; 
Tsai, 2011; 
Donsì, 2011; 
Souguir, 2013 
Aditya, 2015; 
Anand, 2010 
 
 
Resveratrol 
 
A stilbenoid; colourless crystal 
with melting point between 
261-263℃; slightly soluble in 
water and easily soluble in 
organic solvents 
Antioxidant, chemoprevention  
and cardioprotection; anti-
inflammation and anticancer 
Poor water solubility; easily 
oxidized and photosensitive; 
short biological half-life very 
limited oral absorption due to 
rapid and metabolism and 
elimination 
 
Donsì, 2011; 
Wenzel, 2005; 
Shao, 2009; 
Matos, 2014 
 
 
Quercetin 
 
Yellow crystalline powder 
with melting point at 316℃; 
insoluble in water and soluble 
in organic solvents and 
alkaline solutions 
Antioxidant, antiinflammation, 
antitumor, antiviral activities, 
and as well as antiradical and 
hepatoprotective activities 
 
Extreme water insolubility; 
degradation under exposure to 
light; low permeability and rapid 
metabolism before reaching 
systematic circulation 
Kumari, 2011; 
Kumari, 2010; 
Wu, 2008; 
Barras, 2009; 
Scalia, 2009; 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
Chen-yu, 2012 
 
 
 
 
Ellagic acid 
 
Dilactone of 
hexahydroxydiphenic acid; 
yellow acicular crystal with 
melting point>360℃ and 
slightly soluble in water  
antioxidant,antimutagenic,anti
cancer,anti-diabetes,anti-
inflammatory, and apoptosis 
inducing and preventing 
hypertension activity 
Poor water solubility, 
permeability and stability under 
physiological pH; rapid 
metabolism in gastrointestinal 
tract and rapid elimination from 
the body; first pass effect and 
irreversible binding to cellular 
DNA and proteins 
Bala, 2006; 
Sonaje, 2007 
 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
Table 2 Homogenization-solvent removal method for encapsulation of polyphenols 
 
Polyphenols 
 
Encapsulation material 
 
Observations 
 
References 
 
Quercetin 
 
Poly-D,L-lactide (PLA) with 
polyvinyl alcohol (PVA) as 
emulsifier 
 
PLA formed nanoparticles  with higher 
encapsulation efficiency and in vitro 
initial burst release followed by the 
sustained release; less fluorescence 
quenching of encapsulated compound  
than free ones, suggesting controlled 
release 
 
Kamuri et al, 
2011 & 
Kamuri et al, 
2010 
Quercetin Aminoalkyl methacrylate 
Copolymers with PVA as 
emulsifier 
Droplet size depended on the weight 
ratio of EE:PVA; high encapsulation 
efficiency (over 99%); intermolecular 
hydrogen binding of quercetin with 
nanoparticle; higher release rate and 
antioxidant activity of encapsulated 
quercetin than free compound 
 
Wu et al, 2008 
Ellagic  acid Poly lactic-co-glycolic acid 
(PLGA) and  polycaprolactone 
(PCL)with didodecyldimethy-
lammomium bromide (DMAB) 
and PVA, alone and in 
combination with chitosan as 
emulsifier or stabilizer 
Different particle size, encapsulation 
efficiency and release rate were 
observed due to utilization of different 
stabilizer or emulsifier; higher intestinal 
uptake efficiency of encapsulated ellagic 
acid than free drugs; prevention of  
Cyclosporine A-Induced nephrotoxicity 
at three times lower dose suggesting 
improved oral bioavailability 
 
Bala et al, 
2006 & Sonaje 
et al, 2007 
EGCG polylactic acid (PLA)–
polyethylene glycol (PEG) with 
PVA as emulsifier 
Encapsulated EGCG showed  significant 
improved human prostate cancer 
inhibition activity both in vitro and in 
vivo; over 10-fold advantage in 
proapoptotic and angiogenesis inhibitory 
effects; enhanced bioavailability and 
limited unwanted toxicity of 
chemopreventive agents 
 
Siddiqui et al, 
2009 
EGCG PLGA with DMAB as stabilizer EGCG was incorporated into PLGA 
nanoparticles with DMAB as stabilizer; 
encapsulated EGCG was found to be 
equally efficacious as intraperitoneal 
administered in ameliorating  
Cyclosporine A-Induced renal damage 
at three times reduced dose 
 
Italia et al, 
2008 
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EGCG Eudragit S100 as oil phase with 
PVA as emulsifier 
pH-dependent controlled release with 
limited initial burst release; moderated 
bioadhesive property in isolated small 
intestine of rats; significant 
improvement in chemical and metabolic 
stability of EGCG was observed in the 
EGCG/MS, possibly due to the 
controlled release and/or bioadhesion 
 
Onoue et al, 
2011 
Resveratrol mPEG-PCL (methoxy 
poly(ethylene glycol)- 
poly(caprolactone) with 
Higher glioma cell death induced by 
resveratrol-loaded nanoparticles at lower 
concentration compared with free 
compound; significantly lower 
intracellular ROS levels in free 
resveratrol treated cells than 
encapsulated-resveratrol treated cells. 
 
 Shao et al, 
2009 
Curcumin PLGA with PVA  and sucrose  
as emulsifier 
Kept stable for one month at 4 ℃；
significant increase in  plasma 
concentration of curcumin when 
intravenous (55%) or oral (21-fold) 
administered encapsulated curcumin to 
rats; highly improved in vivo 
bioavailability by using encapsulated 
curcumin 
 
Tsai et al, 
2011 
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Highlights: 
 
• Health benefits of polyphenols are dramatically limited by their instability 
• Emulsions are ideal protection and delivery system for polyphenols 
• Emulsion delivery system greatly improve stability and bioavailability of polyphenols 
• Emulsion-entrapped polyphenols showed controlled release and enhanced in vivo 
effects 
